To understand the mechanism of action of the SAHA + SE486-11 combination, we examined the cytotoxicity of combination therapy (1 μM SAHA + 5 μM SE486-11) for a panel of human neuroblastoma cell lines after 48 h of continuous drug exposure, subdivided for the presence or absence of MYCN amplification. Here, MYCN is linked to neuroblastoma.